고혈압 복합제 복용환자에서 동일계열약물 중복 현황

키워드

참고문헌 (39)

1. Kang H-Y, "Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea : the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions", Clin Ther, 31(12), pp.2919~2930 (2009)
2. 김현창, "Korea hypertension fact sheet 2020: analysis of nationwide population-based data", Clinical Hypertension, 27(2), pp.66~69 (2021), 대한고혈압학회[DOI]
3. 이주희, "Current status and therapeutic considerations of hypertension in the elderly", The Korean Journal of Internal Medicine, 34(4), pp.687~695 (2019), 대한내과학회[DOI]
4. 윤흰뫼, "2018년 한국 보건의료의 상대적 위치와 추이: 경제협력개발기구 국가와 비교", 보건행정학회지, 31(2), pp.217~224 (2021), 한국보건행정학회
5. Hae-Young Lee, "2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension", Clinical Hypertension, 25(4), pp.51~74 (2019), 대한고혈압학회[DOI]
6. Flack JM, "Blood pressure and the new ACC", AHA hypertension guidelines, 2020, pp.30(3), 160~164
7. Moriarty F, "Fixed-dose combination antihypertensives and risk of medication errors", Heart, 105(3), pp.204~209 (2019)
8. Gradman AH, "Combination therapy in hypertension", J Am Soc Hypertens, 4(2), pp.90~98 (2010)
9. Kim SH, "Prescribing patterns of antihypertensives for treatment-naïve patients in South Korea : from Korean NHISS claim data", Int J Hypertens, 2019, pp.4735876~ (2019)
10. Takahashi Y, "Social network analysis of duplicative prescriptions : One-month analysis of medical facilities in Japan", Health Policy, 120(3), pp.334~341 (2016)
11. Lim CM, "Use of ATC to describe duplicate medications in primary care prescriptions", Eur J Clin Pharmacol, 67(10), pp.1035~1044 (2011)
12. Al Khaja KAJ, "Potentially inappropriate prescribing in older adults with hypertension or diabetes mellitus and hypertension in a primary care setting in Bahrain", Med Princ Pract, 27(3), pp.241~249 (2018)
13. 손현순, "국내 건강보험심사청구자료에 근거한 다빈도 치료중복 의약품 약효군 분석", 한국임상약학회지, 20(3), pp.262~267 (2010), 한국임상약학회
14. Kim J, "National trends in metformin-based combination therapy of oral hypoglycaemic agents for type 2diabetes mellitus", Eur J Clin Pharmacol, 75(12), pp.1723~1730 (2019)
15. "Drug reimbursement list and table of upper limits"[URL]
16. 최하은, "SGLT2 저해제", metformin 고정용량복합제의 국내 사용 현황, 2022, pp.32(1), 13~19[DOI]
17. Shrestha PL, "Epidemiology of comorbidities in patients with hypertension", Curr Opin Cardiol, 31(4), pp.376~380 (2016)
18. Mohamed SF, "Uncontrolled hypertension among patients with comorbidities in sub-Saharan Africa : protocol for a systematic review and meta-analysis", Syst Rev, 9(1), pp.1~5 (2020)
19. Bangalore S, "Fixed-dose combinations improve medication compliance : a meta-analysis", Am J Med, 120(8), pp.713~719 (2007)
20. Gottwald-Hostalek U, "Management of hypertension with a fixed-dose(single-pill)combination of bisoprolol and amlodipine", Clin Pharmacol Drug Dev, 6(1), pp.9~18 (2017)
21. Bramley DE, "The ability of anaesthetists to identify generic medications from trade names", Anaesth Intensive Care, 37(4), pp.624~629 (2009)
22. Aronson JK, "Medication errors resulting from the confusion of drug names", Expert Opin Drug Saf, 3(3), pp.167~172 (2004)
23. "Therapeutic Duplication"[URL]
24. Golchin N, "Polypharmacy in the elderly", J Res Pharm Pract, 4(2), pp.85~ (2015)
25. Rambhade S, "A survey on polypharmacy and use of inappropriate medications", Toxicol Int, 19(1), pp.68~73 (2012)
26. Jokanovic N, "Prevalence and factors associated with polypharmacy in long-term care facilities : a systematic review", J Am Med Dir Assoc, 16(6), pp.535~ (2015)
27. Cooper JA, "Potentially inappropriate prescribing in two populations with differing socio-economic profiles : a cross-sectional database study using the PROMPT criteria", Eur J Clin Pharmacol, 72(5), pp.583~591 (2016)
28. Salazar JA, "Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable", Expert Opin Drug Saf, 6(6), pp.695~704 (2007)
29. Mason NA, "Polypharmacy and medication-related complications in the chronic kidney disease patient", Curr Opin Nephrol Hypertens, 20(5), pp.492~497 (2011)
30. Paul E. Stevens, "Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline", Annals of Internal Medicine, 158(11), pp.825~830 (2013), American College of Physicians[DOI]
31. Zaman ZA, "Comparison of the effects of amlodipine and cilnidipine on blood pressure, heart rate, proteinuria and lipid profile in hypertensive patients", Int J Basic Clin Pharmacol, 2(2), pp.160~164 (2013)
32. Vrettos I, "Diseases linked to polypharmacy in elderly patients", Curr Gerontol Geriatr Res, 2017, pp.4276047~ (2017)
33. McDonagh TA, "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure : Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)With the special contribution of the Heart Failure Association(HFA)of the ESC", Eur Heart J, 42(36), pp.3599~3726 (2021)
34. 이인향, "보훈의료지원 대상자의 외래 처방의약품 사용경향과 적정성 평가", 한국임상약학회지, 28(2), pp.107~116 (2018), 한국임상약학회[DOI]
35. "2019 Drug reimbursement adequacy evaluation result"[URL]
36. Koo H, "Duplicated tramadol use in chronic low back pain : A nationwide cross-sectional study", Basic Clin Pharmacol Toxicol, 126(3), pp.226~235 (2020)
37. "Criteria for Special Cases concerning the Calculation of Partial Burden of Self-Employee"[URL]
38. Hovstadius B, "Increasing polypharmacy-an individual-based study of the Swedish population 2005-2008", BMC Clin Pharmacol, 10, pp.16~ (2010)
39. Sorensen L, "Medication management at home : medication-related risk factors associated with poor health outcomes", Age Ageing, 34(6), pp.626~632 (2005)

관련 논문AI추천